Announcing the New deCODE

Reykjavik, ICELAND, January 21, 2010 – deCODE genetics ehf today emerged as a newly financed, private company focused on advancing the science of human genetics and its application to products and services that improve human health. The new company will be building on...

deCODE Discovers Four New Risk Factors for Prostate Cancer

Findings further increase power of DNA-based testing to identify men at substantially increased risk, and will be integrated into the deCODE ProstateCancer™ test Reykjavik, ICELAND, September 20, 2009 – deCODE genetics (Nasdaq:DCGN) today announced that a team of its...